PUBLISHER: TechNavio | PRODUCT CODE: 2144558
PUBLISHER: TechNavio | PRODUCT CODE: 2144558
Global Genomics Market 2026-2030
The global genomics market is forecasted to grow by USD 6206.9 mn during 2025-2030, accelerating at a CAGR of 3.2% during the forecast period. The report on the global genomics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing demand for personalized medicine and targeted therapies, expanding government initiatives and funding for genomic research, growth of agricultural genomics for food security.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
| Market Scope | |
|---|---|
| Base Year | 2025 |
| End Year | 2030 |
| Series Year | 2026-2030 |
| Growth Momentum | Accelerate |
| YOY 2026 | 3.2% |
| CAGR | 3.2% |
| Incremental Value | $6206.9 mn |
Technavio's global genomics market is segmented as below:
By Solution
- Products
- Services
By Application
- Diagnostics
- Drug discovery
- Others
By Technology
- Sequencing
- PCR
- Microarray
- CRISPR
Geography
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- The Netherlands
- Asia
- Rest of World (ROW)
- Rest of World (ROW)
This study identifies the rapid advances in spatial biology and single-cell sequencing as one of the prime reasons driving the global genomics market growth during the next few years. Also, proliferation of non-invasive liquid biopsy and advanced diagnostics and integration of ai and large-scale multiomic data analytics will lead to sizable demand in the market.
The report on the global genomics market covers the following areas:
- Global genomics market sizing
- Global genomics market forecast
- Global genomics market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global genomics market vendors that include 10X Genomics Inc., Agilent Technologies Inc., Azenta Inc., Bio Rad Laboratories Inc., Element Biosciences Inc., Eurofins Scientific SE, Exact Sciences Corp., F. Hoffmann La Roche Ltd., Guardant Health Inc., Illumina Inc., Laboratory Holdings Inc., Myriad Genetics Inc., Natera Inc., Oxford Nanopore Technologies, Pacific Biosciences Inc., Personalis Inc., QIAGEN N.V., Quest Diagnostics Inc., Revvity Inc., SOPHiA GENETICS, Standard BioTools Inc., Takara Bio Inc., Tempus AI Inc., Thermo Fisher Scientific Inc.. Also, the global genomics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
- 1.1 Market overview
- Executive Summary - Chart on Market Overview
- Executive Summary - Data Table on Market Overview
- Executive Summary - Chart on Global Market Characteristics
- Executive Summary - Chart on Market by Geography
- Executive Summary - Chart on Market Segmentation by Solution
- Executive Summary - Chart on Market Segmentation by Application
- Executive Summary - Chart on Market Segmentation by Technology
- Executive Summary - Chart on Incremental Growth
- Executive Summary - Data Table on Incremental Growth
- Executive Summary - Chart on Company Market Positioning
2 Technavio Analysis
- 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
- 2.2 Criticality of inputs and Factors of differentiation
- 2.3 Factors of disruption
- 2.4 Impact of drivers and challenges
3 Market Landscape
- 3.1 Market ecosystem
- 3.2 Market characteristics
- 3.3 Value chain analysis
4 Market Sizing
- 4.1 Market definition
- 4.2 Market segment analysis
- Market segments
- 4.3 Market size 2025
- 4.4 Market outlook: Forecast for 2025-2030
5 Historic Market Size
- 5.1 Global Genomics Market 2020 - 2024
- Historic Market Size - Data Table on Global Genomics Market 2020 - 2024 ($ million)
- 5.2 Solution segment analysis 2020 - 2024
- Historic Market Size - Solution Segment 2020 - 2024 ($ million)
- 5.3 Application segment analysis 2020 - 2024
- Historic Market Size - Application Segment 2020 - 2024 ($ million)
- 5.4 Technology segment analysis 2020 - 2024
- Historic Market Size - Technology Segment 2020 - 2024 ($ million)
- 5.5 Geography segment analysis 2020 - 2024
- Historic Market Size - Geography Segment 2020 - 2024 ($ million)
- 5.6 Country segment analysis 2020 - 2024
- Historic Market Size - Country Segment 2020 - 2024 ($ million)
6 Qualitative Analysis
- 6.1 Impact of AI on Global Genomics Market
- 6.2 Impact of Geopolitical Conflicts on Global Genomics Market
7 Five Forces Analysis
- 7.1 Five forces summary
- Five forces analysis - Comparison between 2025 and 2030
- 7.2 Bargaining power of buyers
- Bargaining power of buyers - Impact of key factors 2025 and 2030
- 7.3 Bargaining power of suppliers
- Bargaining power of suppliers - Impact of key factors in 2025 and 2030
- 7.4 Threat of new entrants
- Threat of new entrants - Impact of key factors in 2025 and 2030
- 7.5 Threat of substitutes
- Threat of substitutes - Impact of key factors in 2025 and 2030
- 7.6 Threat of rivalry
- Threat of rivalry - Impact of key factors in 2025 and 2030
- 7.7 Market condition
8 Market Segmentation by Solution
- 8.1 Market segments
- 8.2 Comparison by Solution
- 8.3 Products - Market size and forecast 2025-2030
- 8.4 Services - Market size and forecast 2025-2030
- 8.5 Market opportunity by Solution
- Market opportunity by Solution ($ million)
9 Market Segmentation by Application
- 9.1 Market segments
- 9.2 Comparison by Application
- 9.3 Diagnostics - Market size and forecast 2025-2030
- 9.4 Drug discovery - Market size and forecast 2025-2030
- 9.5 Others - Market size and forecast 2025-2030
- 9.6 Market opportunity by Application
- Market opportunity by Application ($ million)
10 Market Segmentation by Technology
- 10.1 Market segments
- 10.2 Comparison by Technology
- 10.3 Sequencing - Market size and forecast 2025-2030
- 10.4 PCR - Market size and forecast 2025-2030
- 10.5 Microarray - Market size and forecast 2025-2030
- 10.6 CRISPR - Market size and forecast 2025-2030
- 10.7 Market opportunity by Technology
- Market opportunity by Technology ($ million)
11 Customer Landscape
- 11.1 Customer landscape overview
- Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
12 Geographic Landscape
- 12.1 Geographic segmentation
- 12.2 Geographic comparison
- 12.3 North America - Market size and forecast 2025-2030
- 12.3.1 US - Market size and forecast 2025-2030
- 12.3.2 Canada - Market size and forecast 2025-2030
- 12.3.3 Mexico - Market size and forecast 2025-2030
- 12.4 Europe - Market size and forecast 2025-2030
- 12.4.1 Germany - Market size and forecast 2025-2030
- 12.4.2 UK - Market size and forecast 2025-2030
- 12.4.3 France - Market size and forecast 2025-2030
- 12.4.4 Italy - Market size and forecast 2025-2030
- 12.4.5 Spain - Market size and forecast 2025-2030
- 12.4.6 The Netherlands - Market size and forecast 2025-2030
- 12.5 Asia - Market size and forecast 2025-2030
- 12.5.1 China - Market size and forecast 2025-2030
- 12.5.2 Japan - Market size and forecast 2025-2030
- 12.5.3 India - Market size and forecast 2025-2030
- 12.5.4 South Korea - Market size and forecast 2025-2030
- 12.5.5 Singapore - Market size and forecast 2025-2030
- 12.5.6 Thailand - Market size and forecast 2025-2030
- 12.6 Rest of World (ROW) - Market size and forecast 2025-2030
- 12.6.1 Brazil - Market size and forecast 2025-2030
- 12.6.2 Saudi Arabia - Market size and forecast 2025-2030
- 12.6.3 UAE - Market size and forecast 2025-2030
- 12.6.4 Israel - Market size and forecast 2025-2030
- 12.6.5 South Africa - Market size and forecast 2025-2030
- 12.6.6 Argentina - Market size and forecast 2025-2030
- 12.6.7 Egypt - Market size and forecast 2025-2030
- 12.6.8 Chile - Market size and forecast 2025-2030
- 12.7 Market opportunity by geography
- Market opportunity by geography ($ million)
- Data Tables on Market opportunity by geography ($ million)
13 Drivers, Challenges, and Opportunity
- 13.1 Market drivers
- Increasing demand for personalized medicine and targeted therapies
- Expanding government initiatives and funding for genomic research
- Growth of agricultural genomics for food security
- 13.2 Market challenges
- Data privacy and cybersecurity threats
- High capital expenditure and infrastructure costs
- Evolving regulatory frameworks and compliance burdens
- 13.3 Impact of drivers and challenges
- Impact of drivers and challenges in 2025 and 2030
- 13.4 Market opportunities
- Rapid advances in spatial biology and single-cell sequencing
- Proliferation of non-invasive liquid biopsy and advanced diagnostics
- Integration of AI and large-scale multiomic data analytics
14 Competitive Landscape
- 14.1 Overview
- 14.2 Competitive Landscape
- Overview on criticality of inputs and factors of differentiation
- 14.3 Landscape disruption
- Overview on factors of disruption
- 14.4 Industry risks
- Impact of key risks on business
15 Competitive Analysis
- 15.1 Companies profiled
- Companies covered
- 15.2 Company ranking index
- Company ranking index
- 15.3 Market positioning of companies
- Matrix on companies position and classification
- 15.4 Agilent Technologies Inc.
- Agilent Technologies Inc. - Overview
- Agilent Technologies Inc. - Business segments
- Agilent Technologies Inc. - Key news
- Agilent Technologies Inc. - Key offerings
- Agilent Technologies Inc. - Segment focus
- SWOT
- 15.5 Azenta Inc.
- Azenta Inc. - Overview
- Azenta Inc. - Business segments
- Azenta Inc. - Key offerings
- Azenta Inc. - Segment focus
- SWOT
- 15.6 Bio Rad Laboratories Inc.
- Bio Rad Laboratories Inc. - Overview
- Bio Rad Laboratories Inc. - Business segments
- Bio Rad Laboratories Inc. - Key news
- Bio Rad Laboratories Inc. - Key offerings
- Bio Rad Laboratories Inc. - Segment focus
- SWOT
- 15.7 Eurofins Scientific SE
- Eurofins Scientific SE - Overview
- Eurofins Scientific SE - Business segments
- Eurofins Scientific SE - Key offerings
- Eurofins Scientific SE - Segment focus
- SWOT
- 15.8 Exact Sciences Corp.
- Exact Sciences Corp. - Overview
- Exact Sciences Corp. - Product / Service
- Exact Sciences Corp. - Key offerings
- SWOT
- 15.9 F. Hoffmann La Roche Ltd.
- F. Hoffmann La Roche Ltd. - Overview
- F. Hoffmann La Roche Ltd. - Business segments
- F. Hoffmann La Roche Ltd. - Key news
- F. Hoffmann La Roche Ltd. - Key offerings
- F. Hoffmann La Roche Ltd. - Segment focus
- SWOT
- 15.10 Guardant Health Inc.
- Guardant Health Inc. - Overview
- Guardant Health Inc. - Product / Service
- Guardant Health Inc. - Key offerings
- SWOT
- 15.11 Illumina Inc.
- Illumina Inc. - Overview
- Illumina Inc. - Business segments
- Illumina Inc. - Key news
- Illumina Inc. - Key offerings
- Illumina Inc. - Segment focus
- SWOT
- 15.12 Laboratory Holdings Inc.
- Laboratory Holdings Inc. - Overview
- Laboratory Holdings Inc. - Business segments
- Laboratory Holdings Inc. - Key offerings
- Laboratory Holdings Inc. - Segment focus
- SWOT
- 15.13 Natera Inc.
- Natera Inc. - Overview
- Natera Inc. - Business segments
- Natera Inc. - Key offerings
- Natera Inc. - Segment focus
- SWOT
- 15.14 QIAGEN N.V.
- QIAGEN N.V. - Overview
- QIAGEN N.V. - Product / Service
- QIAGEN N.V. - Key offerings
- SWOT
- 15.15 Quest Diagnostics Inc.
- Quest Diagnostics Inc. - Overview
- Quest Diagnostics Inc. - Business segments
- Quest Diagnostics Inc. - Key offerings
- Quest Diagnostics Inc. - Segment focus
- SWOT
- 15.16 Revvity Inc.
- Revvity Inc. - Overview
- Revvity Inc. - Business segments
- Revvity Inc. - Key offerings
- Revvity Inc. - Segment focus
- SWOT
- 15.17 Tempus AI Inc.
- Tempus AI Inc. - Overview
- Tempus AI Inc. - Product / Service
- Tempus AI Inc. - Key offerings
- SWOT
- 15.18 Thermo Fisher Scientific Inc.
- Thermo Fisher Scientific Inc. - Overview
- Thermo Fisher Scientific Inc. - Business segments
- Thermo Fisher Scientific Inc. - Key news
- Thermo Fisher Scientific Inc. - Key offerings
- Thermo Fisher Scientific Inc. - Segment focus
- SWOT
16 Appendix
- 16.1 Scope of the report
- Market definition
- Objectives
- Notes and caveats
- 16.2 Inclusions and exclusions checklist
- Inclusions checklist
- Exclusions checklist
- 16.3 Currency conversion rates for US$
- Currency conversion rates for US$
- 16.4 Research methodology
- Research methodology
- 16.5 Data procurement
- Information sources
- 16.6 Data validation
- Data validation
- 16.7 Validation techniques employed for market sizing
- Validation techniques employed for market sizing
- 16.8 Data synthesis
- Data synthesis
- 16.9 360 degree market analysis
- 360 degree market analysis
- 16.10 List of abbreviations
- List of abbreviations
